Amyloid Pathology and Protein Kinase C (PKC): Possible Therapeutics Effects of PKC Activators
Amyloid β-protein (Aβ) is one of the most studied peptides in human neurodegenerative disorders. Although much has been learned about the biochemistry of this peptide, fundamental questions such as when and how the Aβ becomes pathologic remain unanswered. In this article we review the recent finding...
| Päätekijät: | , , |
|---|---|
| Aineistotyyppi: | Artikkeli |
| Kieli: | English |
| Julkaistu: |
Elsevier
2005-01-01
|
| Sarja: | Journal of Pharmacological Sciences |
| Linkit: | http://www.sciencedirect.com/science/article/pii/S1347861319322844 |